Tao OUYANG

8 clinical trials · Sponsor

Record	Firm	Date
Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy (NCT03270007)	Tao OUYANG	2017-11-10

Every clearance here is in the API, with alerts when new ones post.